{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35385475",
  "DateCompleted": {
    "Year": "2022",
    "Month": "04",
    "Day": "14"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "05",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "04",
        "Day": "06"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e0264438",
      "10.1371/journal.pone.0264438"
    ],
    "Journal": {
      "ISSN": "1932-6203",
      "JournalIssue": {
        "Volume": "17",
        "Issue": "4",
        "PubDate": {
          "Year": "2022"
        }
      },
      "Title": "PloS one",
      "ISOAbbreviation": "PLoS One"
    },
    "ArticleTitle": "Is a single dose of commonly used antibiotics effective in preventing maternal infection after cesarean section? A network meta-analysis.",
    "Pagination": {
      "StartPage": "e0264438",
      "MedlinePgn": "e0264438"
    },
    "Abstract": {
      "AbstractText": [
        "This study aimed to compare the efficacy of different antibiotic classes and dosages in preventing maternal infection after cesarean delivery.",
        "Databases were searched for randomized controlled trials (RCTs) published between January 1980 and January 2021 on antibiotic use for the prevention of maternal infection after cesarean delivery. The outcomes were endometritis, febrile morbidity, and wound infection, reported as odds ratios (OR) and surface under the cumulative ranking curve analysis scores.",
        "A total of 31 RCTs met the inclusion criteria. In the network meta-analysis (NMA) for endometritis, pooled network OR values indicated that the following interventions were superior to placebo: cephalosporins (OR: 0.18, 95% credibility interval [CrI]: 0.07-0.45), penicillins (OR: 0.19, 95% CrI: 0.07-0.50), penicillins (multiple doses) (OR: 0.20, 95% CrI: 0.05-0.65), combination therapies (OR: 0.22, 95% CrI: 0.09-0.54), and cephalosporins (multiple doses) (OR: 0.25, 95% CrI: 0.08-0.74). In the NMA for febrile morbidity, placebo was more effective than the other interventions. In the NMA for wound infection, pooled network OR values indicated that the following interventions were superior to placebo: penicillin (OR: 0.14, 95% CrI: 0.05-0.37), cephalosporins (OR: 0.19, 95% CrI: 0.08-0.41), cephalosporins (multiple doses) (OR: 0.20, 95% CrI: 0.06-0.58), combination therapies (OR: 0.29, 95% CrI: 0.13-0.57), macrolides (OR: 0.33, 95% CrI: 0.15-0.74), and penicillins (multiple doses) (OR: 0.40, 95% CrI: 0.17-0.91).",
        "Compared with placebo, a single dose of commonly used antibiotics may prevent maternal infection after cesarean delivery. However, the incidence of febrile morbidity was not reduced."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, China."
          }
        ],
        "LastName": "Huang",
        "ForeName": "Ye",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Emergency Medicine, National Clinical Research Center of Geriatric Disorders (Xiangya Hospital), Central South University, Changsha, Hunan, China."
          }
        ],
        "LastName": "Yin",
        "ForeName": "Xinbo",
        "Initials": "X"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Emergency Medicine, National Clinical Research Center of Geriatric Disorders (Xiangya Hospital), Central South University, Changsha, Hunan, China."
          }
        ],
        "LastName": "Wang",
        "ForeName": "Xiaokai",
        "Initials": "X"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Emergency Medicine, National Clinical Research Center of Geriatric Disorders (Xiangya Hospital), Central South University, Changsha, Hunan, China."
          }
        ],
        "LastName": "Zhou",
        "ForeName": "Fangyi",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Emergency Medicine, National Clinical Research Center of Geriatric Disorders (Xiangya Hospital), Central South University, Changsha, Hunan, China."
          }
        ],
        "LastName": "Cao",
        "ForeName": "Xiaoxia",
        "Initials": "X"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Emergency Medicine, National Clinical Research Center of Geriatric Disorders (Xiangya Hospital), Central South University, Changsha, Hunan, China."
          }
        ],
        "LastName": "Han",
        "ForeName": "Yeqiong",
        "Initials": "Y"
      },
      {
        "Identifier": [
          "0000-0002-9667-5795"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Emergency Medicine, National Clinical Research Center of Geriatric Disorders (Xiangya Hospital), Central South University, Changsha, Hunan, China."
          }
        ],
        "LastName": "Sun",
        "ForeName": "Shichang",
        "Initials": "S"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Meta-Analysis"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "PLoS One",
    "NlmUniqueID": "101285081",
    "ISSNLinking": "1932-6203"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Cephalosporins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Penicillins"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Cephalosporins"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Cesarean Section"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Endometritis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology",
        "prevention & control"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Network Meta-Analysis"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Penicillins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pregnancy"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Wound Infection"
    }
  ],
  "CoiStatement": "The authors have declared that no competing interests exist."
}